Toggle light / dark theme

Researchers uncover a cellular process that leads to inflammation

Cedars-Sinai investigators have identified several steps in a cellular process responsible for triggering one of the body’s important inflammatory responses. Their findings, published in the journal Science Immunology, open up possibilities for modulating the type of inflammation associated with several infections and inflammatory diseases.

Specifically, the investigators have improved understanding of the steps that lead to the production of IL-1 beta, a potent inflammatory protein signal released during many inflammatory responses.

“We now have a clearer understanding of the stepwise process that leads to the production of IL-1 beta,” said Andrea Wolf, Ph.D., assistant professor of Biomedical Sciences and Medicine at Cedars-Sinai, and a senior and corresponding author on the new study. “By understanding the process, we hope to one day find a treatment for diseases associated with this inflammatory response.”

With Expansion Microscopy, Scientists See Fundamental Cellular Processes

A cell’s identity is based on the genes it expresses, and scientists have been studying gene expression mechanisms for many years. But the process involves molecules that are too small to see, until the recent development of a technique called expansion microscopy. With expansion microscopy, scientists preserve tissue, and then enlarge it; this can make very small structures much easier to see. Researchers have now improved the technology, and even after increasing the size of zebrafish embryonic cell nuclei by 4,000 times, they were able to see the influence of individual molecules on gene expression. The findings, which have enhanced our understanding of gene regulation, have been reported in Science.

With this technique, investigators can now visualize the fundamental processes of the cell that form the basis of life. “We can see processes that we could only imagine before,” said co-senior study author Antonio Giraldez, Ph.D., Fergus F. Wallace Professor of Genetics at Yale School of Medicine.

Grape Seed Proanthocyanidins Did Not Raise NAD (Test Results)

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

At-Home Blood Testing: https://getquantify.io/mlustgarten.

Oral Microbiome: https://www.bristlehealth.com/?ref=michaellustgarten.
Enter Code: ConquerAging.

Green Tea: https://www.ochaandco.com/?ref=conqueraging.

Dr. Khalid Salaita, PhD — Emory University — Developing Novel DNA-Based Mechano-Technologies

Developing Novel DNA-Based Mechano-Technologies For Human Health — Dr. Khalid Salaita, Ph.D. — Emory University


Dr. Khalid Salaita, Ph.D. (https://www.salaitalab.com/salaita) is a Professor of Chemistry at Emory University in Atlanta, Georgia (USA), program faculty in the Department of Biomedical Engineering at Georgia Tech and Emory, program member of Cancer Cell Biology at Winship Cancer Institute, and most recently is the recent winner Future Insight Prize given by Merck KGaA, Darmstadt, Germany (https://www.emdgroup.com/en/research/open-innovation/futurei…aming.html) for his cutting edge work in the area of mechanobiology.

Dr. Salaita earned his B.S. in Chemistry, from Old Dominion University, his Ph.D. in Chemistry from Northwestern University, completed a postdoctoral fellowship in the Department of Chemistry at the University of California, Berkeley, and then started his own lab at Emory University, investigating the interface between living systems and engineered nanoscale materials. To achieve this goal, his group has pioneered the development of tools like molecular force sensors, DNA mechano-technology, smart therapeutics, and nanoscale mechanical actuators to help manipulate living cells.

In recognition of his work, Dr. Salaita has received a number of awards, most notably: the Alfred P. Sloan Research Fellowship, the Camille-Dreyfus Teacher Scholar award, the National Science Foundation Early CAREER award, and the Kavli Fellowship.

Dr. Salaita is currently a member of the Enabling Bioanalytical and Imaging Technologies (EBIT) study Section and an Associate Editor of Smart Materials. His program has been supported by NSF, NIH, and DARPA.

How Deep Sleep Brain Waves Can Impact Blood Sugar Levels

Summary: Deep-sleep brain waves could be a significant factor in regulating blood sugar. The research shows that a combination of sleep spindles and slow waves can predict an increase in insulin sensitivity, subsequently lowering glucose levels.

This discovery highlights sleep as a potential lifestyle adjustment to improve blood sugar control and manage diabetes. Furthermore, these deep-sleep brain waves could also be used to predict an individual’s next-day glucose levels, proving more accurate than traditional sleep metrics.

Expression Patterns and Functions of Cardiac Pigment Epithelium-Derived Factor During Cardiac Development

Objective: This study describes the expression profiles and roles of cardiac pigment epithelium-derived factor (PEDF) during cardiac development.

Methods: Gene datasets from the Gene Expression Omnibus (GEO) database were used to analyze the correlation between cardiac PEDF expression and heart disease. Western blotting.

Immunohistochemistry, histological staining and echocardiography were used to assess the expression patterns and functions of PEDF during cardiac development.

Reversing Biological Aging with Gene Therapy: Ines O’Donovan Interviews Liz Parrish, CEO of BioViva

Have you ever wondered about the future of aging? What if I told you that we’re on the brink of a revolution that could redefine what it means to grow old … with gene therapy.

Today, I want to introduce you to a woman who is not just imagining this future, but actively creating it.

Meet Liz Parrish, the trailblazing CEO of BioViva, a biotech company that’s pushing the boundaries of what’s possible with gene therapies.

Blood Test Plus Personalized Model May Predict Lung Cancer Death Risk

The USPSTF recommends that adults at elevated risk for lung cancer receive a low-dose CT scan each year, which was shown to reduce lung cancer deaths in the 2011 National Lung Screening Trial (NLST). The 2021 USPSTF criteria applies to adults aged 50 to 80 who have at least a 20 PY smoking history and currently smoke or have quit within the past 15 years.

“For individuals who currently are not eligible for lung cancer screening, a positive test may help to identify those possibly at risk for lung cancer death,” said co-corresponding author Edwin Ostrin, MD, PhD, assistant professor of general internal medicine. “We envision this as a tool that could be deployed worldwide, as the future of early detection of this disease.”

Lung cancer causes an estimated 25% of cancer deaths. Early detection improves prospects of survival, but most countries do not screen for it. Fewer than half of all U.S. cases are among people who are eligible under USPSTF guidelines.

New views of a cough: From TB and chronic cough to hope for Parkinson’s

Michael Shiloh had been studying tuberculosis for about two decades when he started wondering about a seemingly basic question: What makes people with TB cough? This is the disease’s hallmark symptom and a main mode of transmission, but despite training as an infectious disease physician and many years of probing the pathogen as a researcher, Shiloh realized that he didn’t know. A quick search of the literature suggested that “essentially nothing had been studied about it, at least not at the molecular level,” he says.

Elucidating the role of cough in illness means first appreciating its role in health. “Cough is one of these critical defensive processes that we have to clear the respiratory system,” says Stuart Mazzone, a neuroscientist at the University of Melbourne. But it also contributes to disease spread, as research by Shiloh, now at the University of Texas Southwestern Medical Center, and others has described. And dysfunctional control of coughing — resulting in too much coughing or not enough — can cause serious health problems.

Here’s a look at how and why we cough, and some of the ways that coughing can go wrong.